Results 21 to 30 of about 988,764 (283)

Safety of Deep Repetitive Transcranial Magnetic Stimulation (drTMS) against Medical Refractory Symptoms in Parkinson Syndromes: First German Real-World Data with a Specific H5 Coil

open access: yesNeurology International, 2022
So far, deep repetitive transcranial magnetic stimulation (drTMS) has shown promising results as an add-on treatment for Parkinson’s disease (PD) but not for non-idiopathic Parkinson Syndromes (PS).
Celine Cont   +7 more
doaj   +1 more source

A Biblical Reflection on the Passion of Jesus Christ as it Relates to 20 Years of Treatment-resistant Ministerial Depression

open access: yesChristian Journal for Global Health, 2019
This is a reflective commentary on the article entitled, Understanding Refractory Depression: A Missionary’s Autobiographical Case Report. It is a focus on a spiritual therapy to minimize the debilitating symptoms of long-term refractory depression when ...
Hunter York
doaj   +1 more source

Psychoanalytic and psychodynamic therapies for depression. The evidence base. [PDF]

open access: yes, 2008
David Taylor, a consultant psychotherapist at the Tavistock & Portman NHS Foundation Trust (120 Belsize Lane, London NW3 5BA, UK. Email: dtaylor@tavi-port.nhs.uk), is the clinical lead of the Tavistock Adult Depression Study (a randomised controlled ...
Taylor, David, David Taylor
core   +1 more source

Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis

open access: yesNeuropsychiatric Disease and Treatment, 2022
Peng Liu,1,2 Shan-Shan Zhang,1,2 Yun Liang,1,2 Zi-Jun Gao,1 Wei Gao,3 Bu-Huai Dong1 1Department of Anesthesiology, Xi’an Honghui Hospital, Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of China; 2Xi’an Medical University, Xi ...
Liu P   +5 more
doaj  

Electroconvulsive therapy in Parkinson´s disease

open access: yesArquivos de Neuro-Psiquiatria, 2015
Purpose To analyze the effectiveness of electroconvulsive therapy for the management of depression and/or psychosis refractory to drug therapy in patients with Parkinson disease.Methods A retrospective study was carried out including patients treated ...
Humberto Calderón-Fajardo   +5 more
doaj   +1 more source

A Deep Brain Stimulation (DBS) for the Treatment of Refractory Depression: A Review of the Literature

open access: yesProceedings
Introduction: Depression is a chronic and multifactorial psychiatric illness that causes symptoms such as profound sadness, discouragement, loss of interest in activities, changes in sleep and appetite, and negative thoughts [...]
Maria F. O. Melo   +9 more
doaj   +1 more source

Lateral habenula astroglia modulate the potentiating antidepressant-like effects of bright light stimulation in intractable depression

open access: yesFrontiers in Pharmacology
BackgroundBeside image vision, light plays a pivotal role in regulating diverse non-visual functions, including affective behaviors. Recently, bright light stimulation (BLS) was revealed to be beneficial for treating non-seasonal depression, although its
Sarah Delcourte   +10 more
doaj   +1 more source

Emergency resuscitation extracorporeal membrane oxygenation (ER ECMO) in 60 saves life

open access: yesJournal of Emergencies, Trauma and Shock, 2023
Aluminum phosphide (ALP) is one of the most commonly used pesticides worldwide with high mortality rates primarily due to the production of phosphene gas which causes severe mitochondrial damage leading to refractory myocardial depression, refractory ...
Gowtham Vijayakumar   +4 more
doaj   +1 more source

Depressive disorders in patients with pharmaco-resistant mesial temporal lobe epilepsy

open access: yesJournal of International Medical Research, 2018
Objectives To assess depressive disorders in patients with mesial temporal lobe epilepsy (MTLE) refractory to medical treatment. Methods Adult patients with refractory MTLE completed two questionnaires (Mini International Neuropsychiatric Interview (MINI)
Eleonora Borges Gonçalves   +3 more
doaj   +1 more source

Validation of Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric Measures for Children With Chronic Nonbacterial Osteomyelitis

open access: yesArthritis Care &Research, EarlyView.
Objective To assess the validity of the Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric measures in patients with chronic nonbacterial osteomyelitis (CNO). Methods Within the longitudinal patient registry of CNO, English‐speaking patients aged 8 years and older self‐reported PROMIS Pediatric measures of fatigue, pain ...
Mary M. Eckert   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy